A customer relationship has several product stories
One physician may be a regular user of Product A and only evaluating Product B. Pharmaceutical adoption cannot be represented accurately by a single doctor-level status. VANTAGE models the ladder by authorised company, contact and product.
The agreed stages are First Visit, Trial, User, Regular User, Heavy User and KOL. Heavy use describes sustained product engagement; KOL is a separate scientifically documented influence role, not an automatic sales-volume promotion.
Different audiences need different account structures
Doctors require contact-by-product adoption records; hospitals require institution, site, department, procurement and stakeholder structures; pharmacies require branches, responsible pharmacists and their visit history.
A hospital procurement process or pharmacy staff-training need should not be forced into the same adoption-stage ladder as an individual prescriber.
Plan the right next interaction
Before a visit, a representative needs the contact’s history, the product’s adoption stage, recorded objections, previous materials and planned milestone. After a visit, the representative should be able to record a genuine outcome and update the relevant product-stage evidence.
The next recommended step should be tailored: education after an initial visit, discussion of experience after trial, sustained-use support for regular users, or scientific engagement appropriate to a documented KOL.
Materials follow the adoption stage
A product repository should hold approved, versioned and audience-appropriate materials. The representative can find the right document for the product and stage rather than searching through unrelated files.
Medical, promotional, consent and country-specific rules still govern actual communications. Clinical claims and outreach require appropriate human and regulatory review.
Managers need more than call counts
Evaluate completed and credited visits, required frequency, territory potential, product-stage progression, commercial results and observed access barriers. Rising activity with stagnant adoption may indicate an education gap or a product-fit problem rather than insufficient effort.
VANTAGE Pharma is an optional specialist module. Ordinary visit planning, account records, routes and the core intelligence dashboard remain part of Intelligent CRM.